139
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Pro-oxidant–antioxidant balance in Iranian veterans with sulfur mustard toxicity and different levels of pulmonary disorders

, , , , , , , & show all
Pages 362-366 | Received 31 Dec 2014, Accepted 16 Nov 2015, Published online: 17 Dec 2015

References

  • Alamdari DH, Ghayour-Mobarhan M, Tavallaie S, et al. (2008). Prooxidant–antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem 41:375–380
  • Alamdari DH, Ordoudi SA, Nenadis N, et al. (2009). Comparison of prooxidant–antioxidant balance method with crocin method for determination of total prooxidant–antioxidant capacity. Iran J Basic Med Sci 12:93–99
  • Alamdari DH, Paletas K, Pegiou T, et al. (2007). A novel assay for the evaluation of the prooxidant–antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin Biochem 40:248–254
  • Anand T, Vijayaraghavan R, Bansal I, Bhattacharya B. (2009). Role of inflammatory cytokines and DNA damage repair proteins in sulfur mustard exposed mice liver. Toxicol Mech Methods 19:356–362
  • Anderson MT, Staal F, Gitler C, Herzenberg LA. (1994). Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. Proc Natl Acad Sci 91:11527–11531
  • Arroyo CM, Broomfield CA, Hackley BE. (2001). The role of interleukin-6 (IL-6) in human sulfur mustard (HD) toxicology. Int J Toxicol 20:281–296
  • Arroyo CM, Kan RK, Burman DL, et al. (2003). Regulation of 1‐α, 25‐dihydroxyvitamin D3 on interleukin‐6 and interleukin‐8 induced by sulfur mustard (HD) on human skin cells. Pharmacol Toxicol 92:204–213
  • Arroyo C, Schafer R, Kurt E, et al. (1999). Response of normal human keratinocytes to sulfur mustard (HD): cytokine release using a non-enzymatic detachment procedure. Hum Exp Toxicol 18:1–11
  • Arroyo CM, Schafer RJ, Kurt EM, et al. (2000). Response of normal human keratinocytes to sulfur mustards: cytokine release. J Appl Toxicol 20:S63–S72
  • Attaran D, Lari SM, Towhidi M, et al. (2010). Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 5:335–340
  • Balali-Mood M, Hefazi M. (2005). The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol 19:297–315
  • Behr J, Maier K, Braun B, et al. (2000). Evidence for oxidative stress in bronchiolitis obliterans syndrome after lung and heart–lung transplantation. Transplantation 69:1856–1860
  • Benzie IF, Strain J. (1996). The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239:70–76
  • Black AT, Joseph LB, Casillas RP, et al. (2010). Role of MAP kinases in regulating expression of antioxidants and inflammatory mediators in mouse keratinocytes following exposure to the half mustard, 2-chloroethyl ethyl sulfide. Toxicol Appl Pharmacol 245:352–360
  • Cao G, Alessio HM, Cutler RG. (1993). Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 14:303–311
  • Comhair SA, Bhathena PR, Dweik RA, et al. (2000). Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. The Lancet 355:624
  • Dong R, Wang Q, He XL, et al. (2007). Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial-mesenchymal transition of MCF-7 cells. Braz J Med Biol Res 40:1071–1078
  • Elsayed NM, Omaye ST, Klain GJ, Korte JRDW. (1992). Free radical-mediated lung response to the monofunctional sulfur mustard butyl 2-chloroethyl sulfide after subcutaneous injection. Toxicology 72:153–165
  • Emad A, Rezaian GR. (1997). The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest J 112:734–738
  • Erel O. (2005). A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111
  • Ham HY, Hong CW, Lee SN, et al. (2012). Sulfur mustard primes human neutrophils for increased degranulation and stimulates cytokine release via TRPM2/p38 MAPK signaling. Toxicol Appl Pharmacol 258:82–88
  • Husain K, Dube S, Sugendran K, et al. (1996). Effect of topically applied sulphur mustard on antioxidant enzymes in blood cells and body tissues of rats. J Appl Toxicol 16:245–248
  • Janssen Y, Marsh J, Absher M, et al. (1992). Expression of antioxidant enzymes in rat lungs after inhalation of asbestos or silica. J Biol Chem 267:10625–10630
  • Johnson JL, Moore EE, Patrick DA, et al. (1999). Extracellular signal-related kinase 1/2 and p38 mitogen-activated protein kinase pathways serve opposite roles in neutrophil cytotoxicity. Arch Surg 134:1074–1078
  • Kirkham P, Rahman I. (2006). Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 111:476–494
  • Kotani K, Taniguchi N. (2012). Correlation between high-sensitivity C-reactive protein and reactive oxygen metabolites during a one-year period among asymptomatic subjects. J Clin Med Res 4:52–55
  • Lardot C, Dubois V, Lison D. (1999). Sulfur mustard upregulates the expression of interleukin-8 in cultured human keratinocytes. Toxicol Lett 110:29–33
  • Li X, Moody MR, Engel D, et al. (2000). Cardiac-specific overexpression of tumor necrosis factor – causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 102:1690–1696
  • Nourani MR, Yazdani S, Habibi Roudkenar M, et al. (2010). HO1 mRNA and protein do not change in parallel in bronchial biopsies of patients after long term exposure to sulfur mustard. Gene Regul Syst Bio 4:83–90
  • Papirmeister B, Feister AJ, Robinson SI, Ford RD. (1991). Medical defense against mustard gas: toxic mechanisms and pharmacological implications. Boca Raton: CRC Press
  • Park S, Kim M, Paik JK, et al. (2013). Oxidative stress is associated with C‐reactive protein in nondiabetic postmenopausal women, independent of obesity and insulin resistance. Clin Endocrinol 79:65–70
  • Paromov V, Suntres Z, Smith M, Stone WL. (2007). Sulfur mustard toxicity following dermal exposure: role of oxidative stress, and antioxidant therapy. J Burns Wounds 7:60–85
  • Pohanka M, Sobotka J, Jilkova M, Stetina R. (2011). Oxidative stress after sulfur mustard intoxication and its reduction by melatonin: efficacy of antioxidant therapy during serious intoxication. Drug Chem Toxicol 34:85–91
  • Rebholz B, Kehe K, Ruzicka T, Rupec RA. (2008). Role of NF-kappaB/RelA and MAPK pathways in keratinocytes in response to sulfur mustard. J Invest Dermatol 128:1626–1632
  • Renshaw B. (1946). Mechanisms in production of cutaneous injuries by sulfur and nitrogen mustards. Chem Warfare Agents Relat Chem Probl 1:479–520
  • Repine JE, Bast A, Lankhorst I. (1997). Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156:341–357
  • Rowell M, Kehe K, Balszuweit F, Thiermann H. (2009). The chronic effects of sulfur mustard exposure. Toxicology 263:9–11
  • Seagrave J, Weber WM, Grotendorst GR. (2010). Sulfur mustard vapor effects on differentiated human lung cells. Inhal Toxicol 22:896–902
  • Shohrati M, Ghanei M, Shamspour N, et al. (2010). Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung 188:77–83
  • Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. (2004). Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 53:2079–2086
  • United Nations Security Council. (1987). Report of the mission dispatched by the Secretary General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq. S/18852 and S/18852/Addedum 1
  • Vestbo J, Hurd SS, Agusti AG, et al. (2013). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:347–365
  • Wassmann S, Stumpf M, Strehlow K, et al. (2004). Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circul Res 94:534–541
  • Wheeler GP. (1962). Studies related to the mechanisms of action of cytotoxic alkylating agents: a review. Cancer Res 22:651–688
  • Won SY, Kim SR, Maeng S, Jin BK. (2013). Interleukin-13/Interleukin-4-induced oxidative stress contributes to death of prothrombinkringle-2 (pKr-2)-activated microglia. J Neuroimmunol 265:36–42

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.